What is the Mainstreaming Cancer Genetics Programme?

Our goal is to make genetic testing part of routine cancer patient care, by integrating testing into the cancer patient pathway. We call this ‘Mainstreaming’.

Genetic tests can provide information about the cause of the cancer and can aid decisions about the best treatments and drugs to use. It can also identify relatives of cancer patients at increased risk of cancer and gives them a window of opportunity to decrease their cancer risk.

Watch the video to see how the MCG work is impacting patient lives.
Genetic testing for cancer patients used to be limited and difficult to access.The MCG has developed a fast, accurate, affordable, cancer predisposition gene test, that is being used across the world.

Our streamlined mainstream gene testing process lets cancer patients access testing at one of their routine cancer clinic appointments. It is faster, cheaper and more patient-centred than the previous system. It saves lives and money. Read more here.